Pfizer Inc (PFE) Stock Price, Quote & News

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 212 733 2323

Website: www.pfizer.com

Address:

66 Hudson Boulevard East, New York, United States

SavannaColes555 Aug. 9 at 4:10 AM

$PFE $BB.TSX $BABA $ICP $GDX Pfizer continues advancing its pharmaceutical pipeline, BlackBerry remains focused on cybersecurity and automotive software, Alibaba benefits from Chinese e-commerce and cloud growth, Internet Computer remains tied to blockchain adoption, and GDX provides diversified gold-miner exposure. I'm watching pipeline catalysts, Chinese demand, crypto adoption, and gold prices.

0 · Reply

Ozzyinmtl Aug. 8 at 11:19 PM

$PFE this stock is stuck in this range forever. Great cover call weekly play of done correctly. Plus high dividend, too.

1 · Reply

LivewireHOG Aug. 8 at 11:03 PM

$PFE $LVWR short borrow fee has been between 500-1000% for a week, it’s only a matter of time. Very high short interest and definitely many FTDs. Follow the data and take a bet next week

0 · Reply

LivewireHOG Aug. 8 at 11:00 PM

$LVWR $PFE or at least $HTZ

0 · Reply

LivewireHOG Aug. 8 at 11:00 PM

$PFE not sure why this is trending but let’s do $LVWR next

0 · Reply

Sak12345 Aug. 8 at 10:56 PM

$PFE NEOLIBERALISM YOUR TIME IS GOING TO END IN A BAD BAD WAY. GET OUT BEFORE ITS ALL OVER. https://youtu.be/s0ttKmpijtU?is=qterWMJ_uHEplkHE

0 · Reply

Micheal_Pothead Aug. 8 at 10:48 PM

$PFE why tf are we trending number 1?

1 · Reply

OnlyFibs Aug. 8 at 10:12 PM

$PFE is positioned at $26.67, consolidating right below key moving average resistance as institutional sponsorship anchors the pharmaceutical leader. Flow data highlights heavy multi-week positioning in the $28 strikes, requiring a +4.98% move in the underlying equity to bring them into-the-money. Capitalizing on structured breakout cycles requires exceptional discipline. ⏳ 🌸 Bull Key Levels: Clean volume acceptance and a sustained close over $27.50 confirms buyer dominance for a test of upper overhead resistance. ↗️ 💎 Bear Key Levels: $23.90 serves as the immediate tactical line in the sand that bulls must defend. ↗️ 🔴 Take Profit Targets: $30.00 / $33.00. 🐂 🚀 #hovdid #SmartMoney #ValueInvesting #StockMarket #Growth

0 · Reply

TrendAlpha Aug. 8 at 9:55 PM

MICHAEL BURRY’S PORTFOLIO IS SPLIT- AND THE BETS ARE LOUD His reported positioning shows a major bearish tilt toward high-flying AI names: SHORT - $PLTR → 66% SHORT - $NVDA → 14% Meanwhile, the long side is much smaller: LONG - $PFE → 11% LONG - $HAL → 5% LONG - $SLM → 5% The message is clear: Burry is betting against AI momentum while positioning selectively in value/cyclical names. Would you fade Burry’s short bets - or follow them? Visit my profile for the latest trading ideas, strategies, and market insights.

2 · Reply

TeamSetupAlpha Aug. 8 at 9:51 PM

BERKSHIRE JUST WENT FROM SELLING TO BUYING - WHAT DID THEY LOAD UP ON? Berkshire was a net buyer of nearly $20B in equities in Q2, ending a 14-quarter streak of net selling. My shortlist $TGT $MELI $GIS $PFE $BKNG The real question: Which of these could be hiding in Berkshire’s next filing? Turn post notifications on to get an early entry i do not need to charge you because i actually make money trading

0 · Reply

Pfizer price target lowered to $31 from $35 at Guggenheim

2026-08-06T13:09:00.000Z - 2 days ago

Pfizer’s (PFE) Q2 Earnings Support a Bullish View

2026-08-05T10:45:23.000Z - 3 days ago

Pfizer price target raised to $27 from $26 at BofA

Aug 4, 2026, 10:00 AM EDT - 4 days ago

Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 4 days ago

Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 4 days ago

Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 4 days ago

Pfizer Quarterly report: Q2 2026

2026-08-04T11:39:45.000Z - 4 days ago

Pfizer Stock (PFE) Falls on 2026 Sales Outlook as Cancer Drugs Fuel Q2 Beat

Aug 4, 2026, 7:24 AM EDT - 4 days ago

Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:13 AM EDT - 4 days ago

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Aug 4, 2026, 7:12 AM EDT - 4 days ago

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

BNTX

2026-08-04T10:52:17.000Z - 4 days ago

Pfizer reports Q2 adjusted EPS 77c, consensus 68c

Aug 4, 2026, 6:52 AM EDT - 4 days ago

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

2026-08-04T10:51:36.000Z - 4 days ago

Pfizer backs FY26 adjusted EPS view $2.80-$3.00, consensus $2.95

2026-08-04T10:50:31.000Z - 4 days ago

Pfizer announces expansion of productivity enhancement Initiatives

Aug 4, 2026, 6:45 AM EDT - 4 days ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Aug 3, 2026, 8:10 AM EDT - 5 days ago

5 Things to Know Before the Stock Market Opens on Monday

AMD AZN BMY CAT CVS DASH DIS

Jul 30, 2026, 7:48 AM EDT - 9 days ago

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

2026-07-30T11:03:18.000Z - 9 days ago

Pfizer says LITFULO studies meet co-primary endpoints

Jul 30, 2026, 6:45 AM EDT - 9 days ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

2026-07-29T20:42:19.000Z - 10 days ago

EC authorizes Pfizer, BioNTech XFG-adapted COVID-19 vaccine in EU

BNTX

Jul 29, 2026, 4:30 PM EDT - 10 days ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Jul 22, 2026, 4:48 PM EDT - 17 days ago

Pfizer's prostate cancer drug combination gets US FDA priority review

Jul 22, 2026, 4:30 PM EDT - 17 days ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 21, 2026, 7:10 PM EDT - 18 days ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Jul 16, 2026, 1:39 PM EDT - 23 days ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Jul 10, 2026, 11:23 AM EDT - 4 weeks ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Jul 6, 2026, 10:00 AM EDT - 4 weeks ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jun 29, 2026, 4:43 PM EDT - 5 weeks ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Jun 29, 2026, 1:20 AM EDT - 5 weeks ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 24, 2026, 3:52 PM EDT - 6 weeks ago

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 2:10 PM EDT - 6 weeks ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 10:51 AM EDT - 6 weeks ago

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 23, 2026, 12:10 PM EDT - 6 weeks ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 22, 2026, 4:43 PM EDT - 6 weeks ago

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:30 PM EDT - 6 weeks ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 2:32 PM EDT - 6 weeks ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Jun 18, 2026, 6:52 AM EDT - 7 weeks ago

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:45 AM EDT - 7 weeks ago

Pfizer Announces Chief Financial Officer Transition

Jun 10, 2026, 7:56 AM EDT - 2 months ago

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 9, 2026, 2:07 PM EDT - 2 months ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

Jun 9, 2026, 3:20 AM EDT - 2 months ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Jun 8, 2026, 8:00 AM EDT - 2 months ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:45 AM EDT - 2 months ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update

Jun 6, 2026, 9:06 AM EDT - 2 months ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:00 AM EDT - 2 months ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 4, 2026, 10:00 AM EDT - 2 months ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 6:40 AM EDT - 2 months ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Jun 3, 2026, 2:00 PM EDT - 2 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 31, 2026, 8:00 AM EDT - 2 months ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 30, 2026, 8:00 AM EDT - 2 months ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 29, 2026, 8:00 AM EDT - 2 months ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 28, 2026, 11:10 PM EDT - 2 months ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 7:19 PM EDT - 2 months ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

May 28, 2026, 7:00 PM EDT - 2 months ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 2 months ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 27, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 20, 2026, 9:00 AM EDT - 2 months ago

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

May 20, 2026, 5:08 AM EDT - 2 months ago

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

May 20, 2026, 5:05 AM EDT - 2 months ago

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

SavannaColes555 Aug. 9 at 4:10 AM

0 · Reply

Ozzyinmtl Aug. 8 at 11:19 PM

$PFE this stock is stuck in this range forever. Great cover call weekly play of done correctly. Plus high dividend, too.

1 · Reply

LivewireHOG Aug. 8 at 11:03 PM

$PFE $LVWR short borrow fee has been between 500-1000% for a week, it’s only a matter of time. Very high short interest and definitely many FTDs. Follow the data and take a bet next week

0 · Reply

LivewireHOG Aug. 8 at 11:00 PM

$LVWR $PFE or at least $HTZ

0 · Reply

LivewireHOG Aug. 8 at 11:00 PM

$PFE not sure why this is trending but let’s do $LVWR next

0 · Reply

Sak12345 Aug. 8 at 10:56 PM

$PFE NEOLIBERALISM YOUR TIME IS GOING TO END IN A BAD BAD WAY. GET OUT BEFORE ITS ALL OVER. https://youtu.be/s0ttKmpijtU?is=qterWMJ_uHEplkHE

0 · Reply

Micheal_Pothead Aug. 8 at 10:48 PM

$PFE why tf are we trending number 1?

1 · Reply

OnlyFibs Aug. 8 at 10:12 PM

0 · Reply

TrendAlpha Aug. 8 at 9:55 PM

2 · Reply

TeamSetupAlpha Aug. 8 at 9:51 PM

0 · Reply

TeamSetupAlpha Aug. 8 at 7:22 PM

$PFE insiders are putting real money to work. Nearly $2M in insider buying around the $25S has my attention. If $MRNA can stage a solid rally this year, why can’t $PFE? At these levels, the risk/reward is getting interesting. Watching the $30–$35 zone next. Sometimes the most beaten-down names become the biggest comeback trades I suggest you read my article over them. It is entirely free. You may be able to get some insight If you want to see the high-conviction stocks I’m watching, my full portfolio, and every trade I make… Head to my profile.

0 · Reply

pineconecameo Aug. 8 at 7:15 PM

$PFE thanks for that extra grocery money this week 😘

1 · Reply

Johnny_Lever Aug. 8 at 6:08 PM

That's the cleanest post-ER move I've seen with $PFE in a long time.

2 · Reply

cmhuff Aug. 8 at 4:48 PM

$PFE Got caught one 25.5 and 26 CC Looking to to sell a put at 26 on half. Next week

0 · Reply

KathleenFinch1000 Aug. 8 at 4:42 PM

$BBVA $UBER $PFE $WDC $DHR BBVA benefits from diversified banking exposure, Uber continues gaining share in mobility and delivery, Pfizer advances its pharmaceutical pipeline, Western Digital benefits from AI-driven storage demand, and Danaher remains a leader in life-science tools. I'm watching margins, demand, and pipeline progress.

0 · Reply

josegodoy Aug. 8 at 1:29 PM

$PFE 😎

0 · Reply

STOCKPICKERTRADER Aug. 8 at 12:26 PM

$PFE continued product diversification and revenue growth coupled with insider buying this week and a nice topping of positive outlook! Solid financials with that juicy dividend as the swing upside on more new products into the market and through trials will put this thing back into 30's - patience.... imho https://finance.yahoo.com/healthcare/articles/pfizers-next-weight-loss-weapon-194800349.html

0 · Reply

taxplanr Aug. 8 at 11:28 AM

The vaccine schedule and nursing homes are the only sales channels for the bioweapons industry $PFE $BNTX $MRNA Fauci and Gates are the most hated on the planet https://www.zerohedge.com/political/what-else-are-they-hiding

1 · Reply

chop14 Aug. 8 at 9:52 AM

$ARTL no rs this year maybe more atm (dilution) 😮 $JNJ $PFE $SLDB

1 · Reply

Mountainmannn Aug. 8 at 3:46 AM

$ABUS up 41% over the phone past year and 19% the last 6 months... I see why this is a bad investment idea.. and people are upset.. $PFE $AMD $MRNA $MRVL

1 · Reply

WholeLottaOptions Aug. 8 at 2:52 AM

$PFE largest insider buy ever, black swan even incoming or fluke?

2 · Reply

Spiceman63 Aug. 7 at 11:23 PM

$PFE Nice to see some recent insider purchases. https://www.secform4.com/insider-trading/78003.htm

0 · Reply

Market Cap	152.52B
Revenue (ttm)	62.58B
Net Income (ttm)	7.77B
EPS (ttm)	N/A
PE Ratio	8.59
Forward PE	8.81
Profit Margin	12.42%
Debt to Equity Ratio	0.71

Volume	42,744,000
Avg Vol	44,104,156
Day's Range	N/A - N/A
Shares Out	5.70B
Stochastic %K	100%
Beta	0.34
Analysts	Sell
Price Target	$28.60